Comparison of doublet chemotherapy with monotherapy for vulnerable advanced colorectal cancer patients.

Mitsuhiro Furuta,Kentaro Yamazaki,Takeshi Kawakami,Hiromichi Shirasu,Takahiro Tsushima,Nozomu Machida,Satoshi Hamauchi,Tomoya Yokota,Akiko Todaka,Akira Fukutomi,Yusuke Onozawa,Hirofumi Yasui

Comparison of doublet chemotherapy with monotherapy for vulnerable advanced colorectal cancer patients.

2020

Mitsuhiro Furuta
Kentaro Yamazaki
Takeshi Kawakami
Hiromichi Shirasu
Takahiro Tsushima
Nozomu Machida
Satoshi Hamauchi
Tomoya Yokota
Akiko Todaka
Akira Fukutomi
Yusuke Onozawa
Hirofumi Yasui

143Background: The efficacy of doublet chemotherapy (fluoropyrimidine + oxaliplatin/irinotecan) for vulnerable colorectal cancer patients is controversial. Some prospective trials have not shown th...

Keywords:

Internal medicine
Medicine
Chemotherapy
Colorectal cancer
Oncology
Pathology
advanced colorectal cancer
Irinotecan
Oxaliplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations